Literature DB >> 7728756

Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands.

A A Dlugosz1, C Cheng, E K Williams, N Darwiche, P J Dempsey, B Mann, A R Dunn, R J Coffey, S H Yuspa.   

Abstract

Autocrine epidermal growth factor receptor activation by transforming growth factor alpha (TGF alpha) has been implicated in growth stimulation during epithelial neoplasia. Using keratinocytes isolated from mice with genetic defects in TGF alpha expression, we tested whether TGF alpha is required for transformation by the v-rasHa oncogene. Introduction of v-rasHa into primary epidermal cultures using a retroviral vector stimulated growth of both control (TGF alpha +/+, BALB/c) and TGF alpha-deficient (TGF alpha -/-, wa-1) keratinocytes. Moreover, v-rasHa elicited characteristic changes in marker expression (keratin 1 was suppressed; keratin 8 was induced), previously shown to be associated with epidermal growth factor (EGF) receptor activation, in both TGF alpha +/+ and TGF alpha -/- keratinocytes. v-rasHa markedly increased secreted (> 10-fold) and cell-associated (2-3-fold) TGF alpha levels in keratinocytes from TGF alpha +/+ and BALB/c mice, but not TGF alpha -/- or wa-1 mice. Based on Northern blot analysis, v-rasHa induced striking up-regulation of transcripts encoding the additional EGF family members amphiregulin, heparin-binding EGF-like growth factor, and betacellulin in cultured keratinocytes from all four mouse strains. Interestingly, in addition to the normal 4.5-kilobase TGF alpha transcript, wa-1 keratinocytes expressed two additional TGF alpha transcripts, 4.7 and 5.2 kilobases long. All three transcripts were up-regulated in response to v-rasHa, as well as exogenous TGF alpha or keratinocyte growth factor treatment, and were also detected in RNA isolated from wa-1 brain and skin. In vivo, v-rasHa keratinocytes from control as well as TGF alpha-deficient mice produced squamous tumors when grafted onto nude mice, and these lesions expressed high levels of amphiregulin, heparin-binding EGF-like growth factor, and betacellulin mRNA, regardless of their TGF alpha status. These findings indicate that TGF alpha is not essential for epidermal neoplasia induced by the v-rasHa oncogene and suggest that another EGF family member(s) may contribute to autocrine growth stimulation of ras-transformed keratinocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7728756

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Effects of angiotensin II receptor signaling during skin wound healing.

Authors:  Hikaru Takeda; Yohtaro Katagata; Yutaka Hozumi; Shigeo Kondo
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

2.  Differential regulation of cyclooxygenase-2 in nontransformed and ras-transformed intestinal epithelial cells.

Authors:  Jianguo Du; Bo Jiang; John Barnard
Journal:  Neoplasia       Date:  2005-08       Impact factor: 5.715

Review 3.  Oncogenic regulation and function of keratins 8 and 18.

Authors:  R G Oshima; H Baribault; C Caulín
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

4.  Keratinocyte expression of calcitonin gene-related peptide β: implications for neuropathic and inflammatory pain mechanisms.

Authors:  Quanzhi Hou; Travis Barr; Lucy Gee; Jeff Vickers; James Wymer; Elisa Borsani; Luigi Rodella; Spiro Getsios; Trisha Burdo; Elan Eisenberg; Udayan Guha; Robert Lavker; John Kessler; Sridar Chittur; Dennis Fiorino; Frank Rice; Phillip Albrecht
Journal:  Pain       Date:  2011-06-17       Impact factor: 6.961

Review 5.  The autocrine loop of TGF-alpha/EGFR and brain tumors.

Authors:  P Tang; P A Steck; W K Yung
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

6.  Autocrine extracellular signal-regulated kinase (ERK) activation in normal human keratinocytes: metalloproteinase-mediated release of amphiregulin triggers signaling from ErbB1 to ERK.

Authors:  Sanjay Kansra; Stefan W Stoll; Jessica L Johnson; James T Elder
Journal:  Mol Biol Cell       Date:  2004-07-14       Impact factor: 4.138

7.  Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis.

Authors:  Keith Syson Chan; Shigetoshi Sano; Kaoru Kiguchi; Joanne Anders; Nobuyasu Komazawa; Junji Takeda; John DiGiovanni
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

8.  Heparin-binding epidermal growth factor-like growth factor in hippocampus: modulation of expression by seizures and anti-excitotoxic action.

Authors:  L A Opanashuk; R J Mark; J Porter; D Damm; M P Mattson; K B Seroogy
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

9.  Amphiregulin overexpression results in rapidly growing keratinocytic tumors: an in vivo xenograft model of keratoacanthoma.

Authors:  Steven D Billings; Michael D Southall; Tao Li; Paul W Cook; LeeAnn Baldridge; William B Moores; Daniel F Spandau; John G Foley; Jeffrey B Travers
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

10.  Fendiline inhibits K-Ras plasma membrane localization and blocks K-Ras signal transmission.

Authors:  Dharini van der Hoeven; Kwang-jin Cho; Xiaoping Ma; Sravanthi Chigurupati; Robert G Parton; John F Hancock
Journal:  Mol Cell Biol       Date:  2012-11-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.